UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.505

Sortiert nach

Hommage à Franck Bonnetain

Oncologie (Paris, France), 2017-06, Vol.19 (5-6), p.131-132

2017

Volltextzugriff (PDF)

Quel traitement adjuvant de l’adénocarcinome du pancréas aujourd’hui : quelles perspectives ?

Oncologie (Paris, France), 2015-11, Vol.17 (11-12), p.493-499

2015

Volltextzugriff (PDF)

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Annals of oncology, 2017-02, Vol.28 (2), p.339-343

2017

Volltextzugriff (PDF)

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

Annals of oncology, 2012-05, Vol.23 (5), p.1190-1197

2012

Volltextzugriff (PDF)

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

Annals of oncology, 2009-04, Vol.20 (4), p.674-680

2009

Volltextzugriff (PDF)

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Annals of oncology, 2012-11, Vol.23 (11), p.2799-2805

2012

Volltextzugriff (PDF)

Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone

British journal of surgery, 2016-01, Vol.103 (1), p.117-125

2016

Volltextzugriff (PDF)

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer

Annals of oncology, 2006-05, Vol.17 (5), p.827-834

2006

Volltextzugriff (PDF)

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Breast cancer research and treatment, 2014-03, Vol.110 (5), p.1148-1154

2014

Volltextzugriff (PDF)

Traitement adjuvant du cancer colorectal : l’aspirine, une biothérapie ciblée ?

Oncologie (Paris, France), 2014-12, Vol.16 (11-12), p.509-515

2014

Volltextzugriff (PDF)

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)

Annals of oncology, 2005-09, Vol.16 (9), p.1488-1497

2005

Volltextzugriff (PDF)

Colon cancer molecular subtype intratumoral heterogeneity and its prognostic impact: An extensive molecular analysis of the PETACC-8

Annals of oncology, 2018-10, Vol.29, p.viii18-viii18

2018

Volltextzugriff (PDF)

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Annals of oncology, 2002-08, Vol.13 (8), p.1185-1191

2002

Volltextzugriff (PDF)

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

Journal of clinical oncology, 1997-01, Vol.15 (1), p.251-260

1997

Volltextzugriff (PDF)

Cystogastrotomy entirely performed under endosonography guidance for pancreatic pseudocyst: results in six patients

Gastrointestinal endoscopy, 1998-08, Vol.48 (2), p.200-203

1998

Volltextzugriff (PDF)

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Annals of oncology, 2003-03, Vol.14 (3), p.481-489

2003

Volltextzugriff (PDF)

Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer

Diseases of the esophagus, 2012-08, Vol.25 (6), p.527-534

2012

Volltextzugriff (PDF)

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

Annals of oncology, 1996-01, Vol.7 (1), p.95-98

1996

Volltextzugriff (PDF)

Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France

Neuroendocrinology, 2009-02, Vol.89 (2), p.217-222

2009

Volltextzugriff (PDF)

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients

Annals of oncology, 2004-03, Vol.15 (3), p.467-473

2004

Volltextzugriff (PDF)

Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1337-1345

2000

Volltextzugriff (PDF)

Fine-needle aspiration cytology guided by endoscopic ultrasonography : results in 141 patients

Endoscopy, 1995-02, Vol.27 (2), p.171-177

1995

Volltextzugriff (PDF)

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival

Annals of oncology, 2002-05, Vol.13 (5), p.721-729

2002

Volltextzugriff (PDF)

Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: A retrospective 35-year study of 12 patients

Diabetes & metabolism, 2008-09, Vol.34 (4), p.343-348

2008

Volltextzugriff (PDF)

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)

Digestive and liver disease, 2023-12, Vol.55 (12), p.1583-1601

2023

Volltextzugriff (PDF)

1 – 25 von 1.505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.202)
Mit Volltextzugriff
(1.268)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.280)
Japanisch
(178)
Französisch
(140)
Deutsch
(81)
Norwegisch
(4)
Spanisch
(3)
Russisch
(3)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Hommage à Franck Bonnetain

Quel traitement adjuvant de l’adénocarcinome du pancréas aujourd’hui : quelles perspectives ?

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer

Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Traitement adjuvant du cancer colorectal : l’aspirine, une biothérapie ciblée ?

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801)

Colon cancer molecular subtype intratumoral heterogeneity and its prognostic impact: An extensive molecular analysis of the PETACC-8

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

Cystogastrotomy entirely performed under endosonography guidance for pancreatic pseudocyst: results in six patients

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients

Capecitabine, an Oral Fluoropyrimidine Carbamate With Substantial Activity in Advanced Colorectal Cancer: Results of a Randomized Phase II Study

Fine-needle aspiration cytology guided by endoscopic ultrasonography : results in 141 patients

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival

Aggressive multimodal therapy of sporadic malignant insulinoma can improve survival: A retrospective 35-year study of 12 patients

Esophageal cancer - French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR)

Suchergebnisse filtern